Myoblast Transplantation in Skeletal Muscles

Handbook of Stem Cells

Volumn 2, Issue , 2013, Pages 653-664

  Skuk, Daniel ^a   Tremblay, Jacques P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882592594     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-385942-6.00057-3     Document Type: Chapter

References (101)

1. Alameddine H.S., Louboutin J.P., Dehaupas M., Sebille A., Fardeau M. Functional recovery induced by satellite cell grafts in irreversibly injured muscles. Cell Transplant. 1994, 3:3-14.
2. Bacou F., el Andalousi R.B., Daussin P.A., Micallef J.P., Levin J.M., Chammas M., et al. Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle. Cell Transplant. 2004, 13:103-111.
3. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve 1994, S261.
4. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 1999, 144:1113-1122.
5. Betz E.H., Firket H., Reznik M. Some aspects of muscle regeneration. Int. Rev. Cytol. 1966, 19:203-227.
6. Borisov A.B. Regeneration of skeletal and cardiac muscle in mammals: do nonprimate models resemble human pathology?. Wound Repair Regen. 1999, 7:26-35.
7. Bouchentouf M., Benabdallah B.F., Rousseau J., Schwartz L.M., Tremblay J.P. Induction of anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am. J. Transplant. 2007, 7:1491-1505.
8. Bouchentouf M., Benabdallah B.F., Bigey P., Yau T.M., Scherman D., Tremblay J.P. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther. 2008, 15:404-414.
9. Brimah K., Ehrhardt J., Mouly V., Butler-Browne G.S., Partridge T.A., Morgan J.E. Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum. Gene Ther. 2004, 15:1109-1124.
10. Bujold M., Caron N., Camiran G., Mukherjee S., Allen P.D., Tremblay J.P., et al. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Cell Transplant. 2002, 11:759-767.
11. Camirand G., Caron N.J., Turgeon N.A., Rossini A.A., Tremblay J.P. Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation 2002, 73:453-461.
12. Camirand G., Rousseau J., Ducharme M.E., Rothstein D.M., Tremblay J.P. Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am. J. Transplant. 2004, 4:1255-1265.
13. Camirand G., Stephan L., Rousseau J., Sackett M.K., Caron N.J., Mills P., et al. Central tolerance to myogenic cell transplants does not include muscle neoantigens. Transplantation 2008, 85:1791-1801.
14. Cantini M., Massimino M.L., Catani C., Rizzuto R., Brini M., Carraro U. Gene transfer into satellite cell from regenerating muscle: bupivacaine allows beta-Gal transfection and expression in vitro and in vivo. In Vitro Cell. Dev. Biol. Anim. 1994, 30A:131-133.
15. Caron N.J., Asselin I., Morel G., Tremblay J.P. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant. 1999, 8:465-476.
16. Cesar M., Roussanne-Domergue S., Coulet B., Gay S., Micallef J.P., Chammas M., et al. Transplantation of adult myoblasts or adipose tissue precursor cells by high-density injection failed to improve reinnervated skeletal muscles. Muscle Nerve 2008, 37:219-230.
17. Cousins J.C., Woodward K.J., Gross J.G., Partridge T.A., Morgan J.E. Regeneration of skeletal muscle from transplanted immortalized myoblasts is oligoclonal. J. Cell Sci. 2004, 117:3259-3269.
18. Deasy B.M., Jankowski R.J., Huard J. Muscle-derived stem cells: characterization and potential for cell- mediated therapy. Blood Cells Mol. Dis. 2001, 27:924-933.
19. Ehrhardt J., Brimah K., Adkin C., Partridge T., Morgan J. Human muscle precursor cells give rise to functional satellite cells in vivo. Neuromuscul. Disord. 2007, 17:631-638.
20. El Fahime E., Mills P., Lafreniere J.F., Torrente Y., Tremblay J.P. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation. Exp. Cell Res. 2002, 280:169-178.
21. Floyd S.S., Clemens P.R., Ontell M.R., Kochanek S., Day C.S., Yang J., et al. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther. 1998, 5:19-30.
22. Gross J.G., Morgan J.E. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 1999, 22:174-185.
23. Guerette B., Asselin I., Vilquin J.T., Roy R., Tremblay J.P. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995, 18:39-51.
24. Guerette B., Roy R., Tremblay M., Asselin I., Kinoshita I., Puymirat J., et al. Increased granzyme B mRNA after alloincompatible myoblast transplantation. Transplantation 1995, 60:1011-1016.
25. Guerette B., Tremblay G., Vilquin J.T., Asselin I., Gingras M., Roy R., et al. Increased interferon-gamma mRNA expression following alloincompatible myoblast transplantation is inhibited by FK506. Muscle Nerve 1996, 19:829-835.
26. Guerette B., Asselin I., Skuk D., Entman M., Tremblay J.P. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant. 1997, 6:101-107.
27. Guerette B., Skuk D., Celestin F., Huard C., Tardif F., Asselin I., et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 1997, 159:2522-2531.
28. Gussoni E., Blau H.M., Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 1997, 3:970-977.
29. Hale D.A., Dhanireddy K., Bruno D., Kirk A.D. Induction of transplantation tolerance in non-human primate preclinical models. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2005, 360:1723-1737.
30. Hall Z.W., Ralston E. Nuclear domains in muscle cells. Cell 1989, 59:771-772.
31. Heslop L., Beauchamp J.R., Tajbakhsh S., Buckingham M.E., Partridge T.A., Zammit P.S. Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5(nlacZl+) mouse. Gene Ther. 2001, 8:778-783.
32. Huard J., Bouchard J.P., Roy R., Malouin F., Dansereau G., Labrecque C., et al. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992, 15:550-560.
33. Huard J., Acsadi G., Jani A., Massie B., Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 1994, 5:949-958.
34. Irintchev A., Zweyer M., Wernig A. Cellular and molecular reactions in mouse muscles after myoblast implantation. J. Neurocytol. 1995, 24:319-331.
35. Irintchev A., Langer M., Zweyer M., Theisen R., Wernig A. Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J. Physiol. (Lond.) 1997, 500:775-785.
36. Irintchev A., Rosenblatt J.D., Cullen M.J., Zweyer M., Wernig A. Ectopic skeletal muscles derived from myoblasts implanted under the skin. J. Cell Sci. 1998, 111:3287-3297.
37. Jones P.H. Implantation of cultured regenerate muscle cells into adult rat muscle. Exp. Neurol. 1979, 66:602-610.
38. Karpati G., Pouliot Y., Zubrzycka-Gaarn E., Carpenter S., Ray P.N., Worton R.G., et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol. 1989, 135:27-32.
39. Karpati G., Ajdukovic D., Arnold D., Gledhill R.B., Guttman R., Holland P., et al. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 1993, 34:8-17.
40. Kikuchi T., Doerr L., Ashmore C.R. A possible mechanism of phenotypic expression of normal and dystrophic genomes on succinic dehydrogenase activity and fiber size within a single myofiber of muscle transplants. J. Neurol. Sci. 1980, 45:273-286.
41. Kinoshita I., Vilquin J.T., Guerette B., Asselin I., Roy R., Tremblay J.P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994, 17:1407-1415.
42. Kinoshita I., Vilquin J.T., Gravel C., Roy R., Tremblay J.P. Myoblast allotransplantation in primates. Muscle Nerve 1995, 18:1217-1218.
43. Kinoshita I., Roy R., Dugre F.J., Gravel C., Roy B., Goulet M., et al. Myoblast transplantation in monkeys: control of immune response by FK506. J. Neuropathol. Exp. Neurol. 1996, 55:687-697.
44. Kinoshita I., Vilquin J.T., Tremblay J.P. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice. Acta Neuropathol. 1996, 91:489-493.
45. Kinoshita I., Vilquin J.T., Asselin I., Chamberlain J., Tremblay J.P. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve 1998, 21:91-103.
46. Konigsberg I.R. The differentiation of cross-striated myofibrils in short term cell culture. Exp. Cell Res. 1960, 21:414-420.
47. Lafreniere J.F., Mills P., Bouchentouf M., Tremblay J.P. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp. Cell Res. 2006, 312:1127-1141.
48. Lafreniere J.F., Caron M.C., Skuk D., Goulet M., Cheikh A.R., Tremblay J.P. Growth factor co-injection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant. 2009, 18:719-730.
49. Leriche-Guerin K., Anderson L.V., Wrogemann K., Roy B., Goulet M., Tremblay J.P. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul. Disord. 2002, 12:167-173.
50. Lipton B.H., Schultz E. Developmental fate of skeletal muscle satellite cells. Science 1979, 205:1292-1294.
51. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 1995, 333:832-838.
52. Mills P., Dominique J.C., Lafreniere J.F., Bouchentouf M., Tremblay J.P. A synthetic mechano growth factor E peptide enhances myogenic precursor cell transplantation success. Am. J. Transplant. 2007, 7:2247-2259.
53. Mills P., Lafreniere J.F., Benabdallah B.F., Fahime El, el M., Tremblay J.P. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp. Cell Res. 2007, 313:527-537.
54. Moisset P.A., Skuk D., Asselin I., Goulet M., Roy B., Karpati G., et al. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Biochem. Biophys. Res. Commun. 1998, 247:94-99.
55. Morgan J.E., Hoffman E.P., Partridge T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 1990, 111:2437-2449.
56. Negroni E., Riederer I., Chaouch S., Belicchi M., Razini P., di Santo J., et al. In vivo myogenic potential of human CD133(+) muscle-derived stem cells: a quantitative study. Mol. Ther. 2009, 17:1234-1240.
57. Ohtsuka Y., Udaka K., Yamashiro Y., Yagita H., Okumura K. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J. Immunol. 1998, 160:4635-4640.
58. Partridge T.A., Grounds M., Sloper J.C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 1978, 273:306-308.
59. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., Kunkel L.M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989, 337:176-179.
60. Pavlath G.K., Rich K., Webster S.G., Blau H.M. Localization of muscle gene products in nuclear domains. Nature 1989, 337:570-573.
61. Pavlath G.K., Rando T.A., Blau H.M. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell Biol. 1994, 127:1923-1932.
62. Pin C.L., Merrifield P.A. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Dev. Biol. 1997, 188:147-166.
63. Qu Z., Balkir L., van Deutekom J.C., Robbins P.D., Pruchnic R., Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 1998, 142:1257-1267.
64. Quenneville S.P., Tremblay J.P. Ex vivo modification of cells to induce a muscle-based expression. Curr. Gene Ther. 2006, 6:625-632.
65. Quenneville S.P., Chapdelaine P., Rousseau J., Beaulieu J., Caron N.J., Skuk D., et al. Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol. Ther. 2004, 10:679-687.
66. Quenneville S.P., Chapdelaine P., Rousseau J., Tremblay J.P. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Gene Ther. 2007, 14:514-522.
67. Quenneville S.P., Chapdelaine P., Skuk D., Paradis M., Goulet M., Rousseau J., et al. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol. Ther. 2007, 15:431-438.
68. Ralston E., Hall Z.W. Restricted distribution of mRNA produced from a single nucleus in hybrid myotubes. J. Cell Biol. 1992, 119:1063-1068.
69. Richard P.L., Gosselin C., Laliberte T., Paradis M., Goulet M., Tremblay J.P., Skuk D. A first semi-manual device for clinical intramuscular repetitive cell injections. Cell Transplant. 2010, 19:67-78.
70. Sammels L.M., Bosio E., Fragall C.T., Grounds M.D., van Rooijen N., Beilharz M.W. Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 2004, 77:1790-1797.
71. Sampaolesi M., Torrente Y., Innocenzi A., Tonlorenzi R., d'Antona G., Pellegrino M.A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003, 301:487-492.
72. Sampaolesi M., Blot S., d'Antona G., Granger N., Tonlorenzi R., Innocenzi A., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006, 444:574-579.
73. Satoh A., Labrecque C., Tremblay J.P. Myotubes can be formed within implanted adipose tissue. Transplant. Proc. 1992, 24:3017-3019.
74. Skuk D. Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin. Biol. Ther. 2004, 4:1871-1885.
75. Skuk D. Acute rejection of myofibers in nonhuman primates: Key histopathologic features. J. Neuropathol. Exp. Neurol. 2012, 71:398-412.
76. Skuk D., Tremblay J.P. Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J. Muscle Res. Cell Motil. 2003, 24:285-300.
77. Skuk D., Roy B., Goulet M., Tremblay J.P. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp. Neurol. 1999, 155:22-30.
78. Skuk D., Goulet M., Roy B., Tremblay J.P. Myoblast transplantation in whole muscle of non-human primates. J. Neuropathol. Exp. Neurol. 2000, 59:197-206.
79. Skuk D., Goulet M., Roy B., Tremblay J.P. Efficacy of myoblast transplantation in non-human primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp. Neurol. 2002, 175:112-126.
80. Skuk D., Caron N.J., Goulet M., Roy B., Tremblay J.P. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J. Neuropathol. Exp. Neurol. 2003, 62:951-967.
81. Skuk D., Roy B., Goulet M., Chapdelaine P., Bouchard J.P., Roy R., et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther. 2004, 9:475-482.
82. Skuk D., Goulet M., Tremblay J.P. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant. 2006, 15:659-663.
83. Skuk D., Goulet M., Roy B., Chapdelaine P., Bouchard J.P., Roy R., et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. 2006, 65:371-386.
84. Skuk D., Goulet M., Roy B., Piette V., Cote C.H., Chapdelaine P., et al. First test of a 'high-density injection' protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul. Disord. 2007, 17:38-46.
85. Skuk D., Paradis M., Goulet M., Tremblay J.P. Ischemic central necrosis in pockets of transplanted myoblasts in non-human primates: implications for cell-transplantation strategies. Transplantation 2007, 84:1307-1315.
86. Skuk D., Paradis M., Goulet M., Chapdelaine P., Rothstein D.M., Tremblay J.P. Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells. Mol. Ther. 2010, 18:1689-1697.
87. Skuk D., Goulet M., Tremblay J.P. Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in skeletal muscles of nonhuman primates. J. Neuropathol. Exp. Neurol. 2011, 70:770-778.
88. Stephan L., Pichavant C., Bouchentouf M., Mills P., Camirand G., Tagmouti S., et al. Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. Cell Transplant. 2006, 15:835-846.
89. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 1993, 2:99-112.
90. Vilquin J.T., Asselin I., Guerette B., Kinoshita I., Roy R., Tremblay J.P. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 1995, 59:422-426.
91. Vilquin J.T., Kinoshita I., Roy B., Goulet M., Engvall E., Tome F., et al. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J. Cell Biol. 1996, 133:185-197.
92. Ward M.M. Factors predictive of acute renal failure in rhabdomyolysis. Arch. Intern. Med. 1988, 148:1553-1557.
93. Watt D.J., Lambert K., Morgan J.E., Partridge T.A., Sloper J.C. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J. Neurol. Sci. 1982, 57:319-331.
94. Wernig A., Irintchev A. "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J. Neurol. Sci. 1995, 130:190-196.
95. Wernig A., Irintchev A., Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J. Physiol. (Lond.) 1995, 484:493-504.
96. Wernig A., Zweyer M., Irintchev A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J. Physiol. (Lond.) 2000, 522:333-345.
97. Xu X., Xu Z., Xu Y., Cui G. Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron. Artery Dis. 2010, 16:245-255.
98. Yablonka-Reuveni Z., Nameroff M. Temporal differences in desmin expression between myoblasts from embryonic and adult chicken skeletal muscle. Differentiation 1990, 45:21-28.
99. Yao S.N., Kurachi K. Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells. J. Cell Sci. 1993, 105:957-963.
100. Yokota T., Lu Q.L., Morgan J.E., Davies K.E., Fisher R., Takeda S., et al. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J. Cell Sci. 2006, 119:2679-2687.
101. Zheng B., Cao B., Crisan M., Sun B., Li G., Logar A., et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat. Biotechnol. 2007, 25:1025-1034.